4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Zotepine.
Abiraterone
The serum concentration of Zotepine can be increased when it is combined with Abiraterone.
Acepromazine
The risk or severity of adverse effects can be increased when Acepromazine is combined with Zotepine.
Advertisement
Aceprometazine
The risk or severity of adverse effects can be increased when Aceprometazine is combined with Zotepine.
Acetyl Sulfisoxazole
The metabolism of Zotepine can be decreased when combined with Acetyl sulfisoxazole.
Alfaxalone
The risk or severity of adverse effects can be increased when Zotepine is combined with Alfaxalone.
Advertisement
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Zotepine.
Almotriptan
The risk or severity of adverse effects can be increased when Almotriptan is combined with Zotepine.
Alphaprodine
The risk or severity of adverse effects can be increased when Zotepine is combined with Alphaprodine.
Advertisement
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Zotepine.
Amantadine
The therapeutic efficacy of Amantadine can be decreased when used in combination with Zotepine.
Amiodarone
The metabolism of Zotepine can be decreased when combined with Amiodarone.
Amisulpride
Zotepine may increase the antipsychotic activities of Amisulpride.
Amitriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Zotepine.
Amobarbital
The risk or severity of adverse effects can be increased when Amobarbital is combined with Zotepine.
Amoxapine
The risk or severity of adverse effects can be increased when Amoxapine is combined with Zotepine.
Amphetamine
Zotepine may decrease the stimulatory activities of Amphetamine.
Apalutamide
The serum concentration of Zotepine can be decreased when it is combined with Apalutamide.
Apomorphine
The therapeutic efficacy of Apomorphine can be decreased when used in combination with Zotepine.
Aprepitant
The serum concentration of Zotepine can be increased when it is combined with Aprepitant.
Aripiprazole
The risk or severity of adverse effects can be increased when Aripiprazole is combined with Zotepine.
Articaine
The risk or severity of adverse effects can be increased when Articaine is combined with Zotepine.
Asenapine
The risk or severity of adverse effects can be increased when Asenapine is combined with Zotepine.
Atazanavir
The metabolism of Zotepine can be decreased when combined with Atazanavir.
Atomoxetine
The metabolism of Zotepine can be decreased when combined with Atomoxetine.
Azelastine
Zotepine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Azithromycin
The metabolism of Zotepine can be decreased when combined with Azithromycin.
Baclofen
The risk or severity of adverse effects can be increased when Baclofen is combined with Zotepine.
Barbital
The risk or severity of adverse effects can be increased when Barbital is combined with Zotepine.
Benoxinate
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Zotepine.
Benperidol
The risk or severity of adverse effects can be increased when Zotepine is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Benzocaine is combined with Zotepine.
Benzphetamine
Zotepine may decrease the stimulatory activities of Benzphetamine.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Zotepine.
Boceprevir
The metabolism of Zotepine can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Zotepine can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Zotepine can be decreased when it is combined with Bosentan.
Bosentan Anhydrous
The serum concentration of Zotepine can be decreased when it is combined with Bosentan.
Brexpiprazole
The risk or severity of adverse effects can be increased when Brexpiprazole is combined with Zotepine.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Zotepine.
Bromazepam
The risk or severity of adverse effects can be increased when Bromazepam is combined with Zotepine.
Bromocriptine
The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Zotepine.
Bromperidol
The risk or severity of adverse effects can be increased when Zotepine is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Brompheniramine is combined with Zotepine.
Brotizolam
The risk or severity of adverse effects can be increased when Brotizolam is combined with Zotepine.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Zotepine.
Buprenorphine
Zotepine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Zotepine.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Zotepine.
Butalbital
The risk or severity of adverse effects can be increased when Butalbital is combined with Zotepine.
Butamben
The risk or severity of adverse effects can be increased when Zotepine is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Butethal is combined with Zotepine.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Zotepine.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Zotepine.
Caffeine
The metabolism of Zotepine can be decreased when combined with Caffeine.
Carbamazepine
The metabolism of Zotepine can be increased when combined with Carbamazepine.
Carbinoxamine
The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Zotepine.
Carisoprodol
The risk or severity of adverse effects can be increased when Carisoprodol is combined with Zotepine.
Ceritinib
The serum concentration of Zotepine can be increased when it is combined with Ceritinib.
Cetirizine
The risk or severity of adverse effects can be increased when Cetirizine is combined with Zotepine.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Zotepine.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Zotepine.
Chlormethiazole
The risk or severity of adverse effects can be increased when clomethiazole is combined with Zotepine.
Chlormezanone
The risk or severity of adverse effects can be increased when Chlormezanone is combined with Zotepine.
Chloroprocaine
The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Zotepine.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Zotepine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Zotepine.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Zotepine.
Chlorprothixene
The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Zotepine.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Zotepine.
Citalopram
The risk or severity of adverse effects can be increased when Zotepine is combined with Citalopram.
Clarithromycin
The metabolism of Zotepine can be decreased when combined with Clarithromycin.
Clemastine
The risk or severity of adverse effects can be increased when Clemastine is combined with Zotepine.
Clidinium
The risk or severity of adverse effects can be increased when Clidinium is combined with Zotepine.
Clidinium bromide
The risk or severity of adverse effects can be increased when Clidinium is combined with Zotepine.
Clobazam
The risk or severity of adverse effects can be increased when Clobazam is combined with Zotepine.
Clomipramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Zotepine.
Clonazepam
The risk or severity of adverse effects can be increased when Clonazepam is combined with Zotepine.
Clonidine
The risk or severity of adverse effects can be increased when Clonidine is combined with Zotepine.
Clorazepate
The risk or severity of adverse effects can be increased when Clorazepate is combined with Zotepine.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Clorazepate is combined with Zotepine.
Clotrimazole
The metabolism of Zotepine can be decreased when combined with Clotrimazole.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Zotepine.
Cobicistat
The metabolism of Zotepine can be decreased when combined with Cobicistat.
Cocaine
The risk or severity of adverse effects can be increased when Cocaine is combined with Zotepine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Zotepine.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Zotepine.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Zotepine.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Zotepine.
Crizotinib
The metabolism of Zotepine can be decreased when combined with Crizotinib.
Curcumin
The metabolism of Zotepine can be decreased when combined with Curcumin.
Cyclizine
The risk or severity of adverse effects can be increased when Cyclizine is combined with Zotepine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Zotepine.
Cyclosporine
The metabolism of Zotepine can be decreased when combined with Cyclosporine.
Cyproheptadine
The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Zotepine.
Cyproterone Acetate
The serum concentration of Zotepine can be decreased when it is combined with Cyproterone acetate.
Dabrafenib
The serum concentration of Zotepine can be decreased when it is combined with Dabrafenib.
Dantrolene
The risk or severity of adverse effects can be increased when Dantrolene is combined with Zotepine.
Dapiprazole
The risk or severity of adverse effects can be increased when Dapiprazole is combined with Zotepine.
Darunavir
The metabolism of Zotepine can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Zotepine can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Zotepine can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Zotepine can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Zotepine can be decreased when combined with Delavirdine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Zotepine.
Desipramine
The risk or severity of adverse effects can be increased when Desipramine is combined with Zotepine.
Desloratadine
The risk or severity of adverse effects can be increased when Desloratadine is combined with Zotepine.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Zotepine is combined with Desvenlafaxine.
Deutetrabenazine
The risk or severity of adverse effects can be increased when Zotepine is combined with Deutetrabenazine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Zotepine.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Zotepine.
Dextroamphetamine
Zotepine may decrease the stimulatory activities of Dextroamphetamine.
Dextromethorphan
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Zotepine.
Dextromoramide
The risk or severity of adverse effects can be increased when Dextromoramide is combined with Zotepine.
Dezocine
The risk or severity of adverse effects can be increased when Dezocine is combined with Zotepine.
Diazepam
The risk or severity of adverse effects can be increased when Diazepam is combined with Zotepine.
Dibucaine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Zotepine.
Diethylpropion
Zotepine may decrease the stimulatory activities of Diethylpropion.
Difenoxin
The risk or severity of adverse effects can be increased when Difenoxin is combined with Zotepine.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Zotepine.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Zotepine.
Diltiazem
The metabolism of Zotepine can be decreased when combined with Diltiazem.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Zotepine.
Diphenhydramine
The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Zotepine.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Zotepine.
Dothiepin
The metabolism of Zotepine can be decreased when combined with Dosulepin.
Doxepin
The risk or severity of adverse effects can be increased when Doxepin is combined with Zotepine.
Doxycycline
The metabolism of Zotepine can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Zotepine can be decreased when combined with Doxycycline.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Zotepine.
Dronedarone
The metabolism of Zotepine can be decreased when combined with Dronedarone.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Zotepine.
Duloxetine
The risk or severity of adverse effects can be increased when Zotepine is combined with Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Dyclonine is combined with Zotepine.
Efavirenz
The risk or severity of adverse effects can be increased when Efavirenz is combined with Zotepine.
Eletriptan
The risk or severity of adverse effects can be increased when Eletriptan is combined with Zotepine.
Enflurane
The risk or severity of adverse effects can be increased when Enflurane is combined with Zotepine.
Entacapone
The risk or severity of adverse effects can be increased when Entacapone is combined with Zotepine.
Enzalutamide
The serum concentration of Zotepine can be decreased when it is combined with Enzalutamide.
ergoloid mesylates, USP
The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Zotepine.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Zotepine.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Zotepine.
Erythromycin
The metabolism of Zotepine can be decreased when combined with Erythromycin.
Escitalopram
The risk or severity of adverse effects can be increased when Zotepine is combined with Escitalopram.
Estazolam
The risk or severity of adverse effects can be increased when Estazolam is combined with Zotepine.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Zotepine.
Ethanol
Zotepine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Zotepine.
Ethosuximide
The risk or severity of adverse effects can be increased when Ethosuximide is combined with Zotepine.
Ethotoin
The risk or severity of adverse effects can be increased when Ethotoin is combined with Zotepine.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Zotepine is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Zotepine.
Ethylmorphine
The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Zotepine.
Etidocaine
The risk or severity of adverse effects can be increased when Etidocaine is combined with Zotepine.
Etifoxine
The risk or severity of adverse effects can be increased when Etifoxine is combined with Zotepine.
Etomidate
The risk or severity of adverse effects can be increased when Etomidate is combined with Zotepine.
Ezogabine
The risk or severity of adverse effects can be increased when Ezogabine is combined with Zotepine.
Felbamate
The risk or severity of adverse effects can be increased when Felbamate is combined with Zotepine.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Zotepine.
Fexofenadine
The risk or severity of adverse effects can be increased when Fexofenadine is combined with Zotepine.
Flibanserin
The risk or severity of adverse effects can be increased when Flibanserin is combined with Zotepine.
Fluconazole
The metabolism of Zotepine can be decreased when combined with Fluconazole.
Flunarizine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Zotepine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Zotepine.
Fluoxetine
The risk or severity of adverse effects can be increased when Zotepine is combined with Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Flupentixol is combined with Zotepine.
Fluphenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Zotepine.
Flurazepam
The risk or severity of adverse effects can be increased when Flurazepam is combined with Zotepine.
Fluspirilene
The risk or severity of adverse effects can be increased when Fluspirilene is combined with Zotepine.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Zotepine.
Fluvoxamine
The metabolism of Zotepine can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Zotepine can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Zotepine can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Zotepine can be increased when combined with Fosphenytoin.
Fospropofol
The risk or severity of adverse effects can be increased when Fospropofol is combined with Zotepine.
Frovatriptan
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Zotepine.
Fusidate
The serum concentration of Zotepine can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Zotepine can be increased when it is combined with Fusidic Acid.
Gabapentin
The risk or severity of adverse effects can be increased when Gabapentin is combined with Zotepine.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Zotepine.
Glutethimide
The risk or severity of adverse effects can be increased when Glutethimide is combined with Zotepine.
Guanfacine
The risk or severity of adverse effects can be increased when Guanfacine is combined with Zotepine.
Halazepam
The risk or severity of adverse effects can be increased when Halazepam is combined with Zotepine.
Haloperidol
The risk or severity of adverse effects can be increased when Haloperidol is combined with Zotepine.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Zotepine.
Heroin
The risk or severity of adverse effects can be increased when Heroin is combined with Zotepine.
Hexobarbital
The risk or severity of adverse effects can be increased when Hexobarbital is combined with Zotepine.
Hydrocodone
Zotepine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Zotepine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Zotepine.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Zotepine.
Hypoxis hemerocallidea root extract
The serum concentration of Zotepine can be decreased when it is combined with St. John's Wort.
Idelalisib
The metabolism of Zotepine can be decreased when combined with Idelalisib.
Iloperidone
The risk or severity of adverse effects can be increased when Iloperidone is combined with Zotepine.
Imatinib
The metabolism of Zotepine can be decreased when combined with Imatinib.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Zotepine.
Indinavir
The metabolism of Zotepine can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Zotepine can be decreased when combined with Indinavir.
Isavuconazole
The serum concentration of Zotepine can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Zotepine can be decreased when combined with Isavuconazonium.
Isocarboxazid
The therapeutic efficacy of Zotepine can be increased when used in combination with Isocarboxazid.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Zotepine.
Isradipine
The metabolism of Zotepine can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Zotepine can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Zotepine can be increased when it is combined with Ivacaftor.
Ketamine
The risk or severity of adverse effects can be increased when Ketamine is combined with Zotepine.
Ketazolam
The risk or severity of adverse effects can be increased when Ketazolam is combined with Zotepine.
Ketoconazole
The metabolism of Zotepine can be decreased when combined with Ketoconazole.
Lamotrigine
The risk or severity of adverse effects can be increased when Lamotrigine is combined with Zotepine.
Levetiracetam
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Zotepine.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Zotepine.
Levocabastine
The risk or severity of adverse effects can be increased when Zotepine is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Zotepine.
Levodopa
The therapeutic efficacy of Levodopa can be decreased when used in combination with Zotepine.
Levomethadyl
The risk or severity of adverse effects can be increased when Levomethadyl Acetate is combined with Zotepine.
Levomilnacipran
The risk or severity of adverse effects can be increased when Zotepine is combined with Levomilnacipran.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Zotepine.
Lidocaine
The risk or severity of adverse effects can be increased when Lidocaine is combined with Zotepine.
Linezolid
The risk or severity of adverse effects can be increased when Linezolid is combined with Zotepine.
Lisdexamfetamine
Zotepine may decrease the stimulatory activities of Lisdexamfetamine.
Lisdexamfetamine Dimesylate
Zotepine may decrease the stimulatory activities of Lisdexamfetamine.
Lithium
Lithium may increase the neurotoxic activities of Zotepine.
Lithium Cation
Lithium may increase the neurotoxic activities of Zotepine.
Lofexidine
The therapeutic efficacy of Zotepine can be increased when used in combination with Lofexidine.
Lopinavir
The metabolism of Zotepine can be decreased when combined with Lopinavir.
Loratadine
The risk or severity of adverse effects can be increased when Loratadine is combined with Zotepine.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Zotepine.
Lorcaserin
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Zotepine.
Lormetazepam
The risk or severity of adverse effects can be increased when Zotepine is combined with Lormetazepam.
Lovastatin
The metabolism of Zotepine can be decreased when combined with Lovastatin.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Zotepine.
Luliconazole
The serum concentration of Zotepine can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Zotepine can be increased when combined with Lumacaftor.
Lurasidone
The risk or severity of adverse effects can be increased when Lurasidone is combined with Zotepine.
Magnesium Sulfate
The therapeutic efficacy of Zotepine can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Zotepine can be increased when used in combination with Magnesium sulfate.
Maprotiline
The risk or severity of adverse effects can be increased when Maprotiline is combined with Zotepine.
Meclizine
The risk or severity of adverse effects can be increased when Meclizine is combined with Zotepine.
Melatonin
The risk or severity of adverse effects can be increased when Melatonin is combined with Zotepine.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Zotepine.
Mephentermine
Zotepine may decrease the stimulatory activities of Mephentermine.
Mephobarbital
The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Zotepine.
Mepivacaine
The risk or severity of adverse effects can be increased when Mepivacaine is combined with Zotepine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Zotepine.
Mequitazine
Zotepine may increase the arrhythmogenic activities of Mequitazine.
Mesoridazine
The risk or severity of adverse effects can be increased when Mesoridazine is combined with Zotepine.
Metaxalone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Zotepine.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Zotepine.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Methadyl Acetate is combined with Zotepine.
Methamphetamine
Zotepine may decrease the stimulatory activities of Methamphetamine.
Methapyrilene
The risk or severity of adverse effects can be increased when Methapyrilene is combined with Zotepine.
Methaqualone
The risk or severity of adverse effects can be increased when Methaqualone is combined with Zotepine.
Methocarbamol
The risk or severity of adverse effects can be increased when Methocarbamol is combined with Zotepine.
Methohexital
The risk or severity of adverse effects can be increased when Methohexital is combined with Zotepine.
Methotrimeprazine
Zotepine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Zotepine.
Methsuximide
The risk or severity of adverse effects can be increased when Methsuximide is combined with Zotepine.
Methylphenidate
The risk or severity of adverse effects can be increased when Zotepine is combined with Methylphenidate.
Metoclopramide
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Zotepine.
Metylperon
The risk or severity of adverse effects can be increased when Melperone is combined with Zotepine.
Metyrosine
Zotepine may increase the sedative activities of Metyrosine.
Mexiletine
The metabolism of Zotepine can be decreased when combined with Mexiletine.
Midazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Zotepine.
Midostaurin
The metabolism of Zotepine can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Zotepine can be increased when it is combined with Mifepristone.
Milnacipran
The risk or severity of adverse effects can be increased when Zotepine is combined with Milnacipran.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Zotepine.
Mirtazapine
Zotepine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Mitotane
The serum concentration of Zotepine can be decreased when it is combined with Mitotane.
Moclobemide
The risk or severity of adverse effects can be increased when Moclobemide is combined with Zotepine.
Molindone
The risk or severity of adverse effects can be increased when Molindone is combined with Zotepine.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Zotepine.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Zotepine.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Zotepine.
Naratriptan
The risk or severity of adverse effects can be increased when Naratriptan is combined with Zotepine.
Nefazodone
The metabolism of Zotepine can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Zotepine can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Zotepine can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Zotepine can be increased when combined with Nevirapine.
Nilotinib
The metabolism of Zotepine can be decreased when combined with Nilotinib.
Nitrazepam
The risk or severity of adverse effects can be increased when Nitrazepam is combined with Zotepine.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Zotepine.
Nordazepam
The risk or severity of adverse effects can be increased when Zotepine is combined with Nordazepam.
Norflurane
The risk or severity of adverse effects can be increased when Zotepine is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Zotepine is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Zotepine.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Zotepine.
Olaparib
The metabolism of Zotepine can be decreased when combined with Olaparib.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Zotepine.
Ondansetron
The risk or severity of adverse effects can be increased when Ondansetron is combined with Zotepine.
Opium
The risk or severity of adverse effects can be increased when Zotepine is combined with Opium.
Orphenadrine
Zotepine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Osimertinib
The serum concentration of Zotepine can be increased when it is combined with Osimertinib.
Oxazepam
The risk or severity of adverse effects can be increased when Oxazepam is combined with Zotepine.
Oxprenolol
The risk or severity of adverse effects can be increased when Oxprenolol is combined with Zotepine.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Zotepine.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Zotepine.
p-Hydroxyamphetamine
Zotepine may decrease the stimulatory activities of Hydroxyamphetamine.
Palbociclib
The serum concentration of Zotepine can be increased when it is combined with Palbociclib.
Paliperidone
The risk or severity of adverse effects can be increased when Paliperidone is combined with Zotepine.
Paraldehyde
Zotepine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Zotepine.
Paroxetine
The risk or severity of adverse effects can be increased when Zotepine is combined with Paroxetine.
Peginterferon Alfa-2b
The serum concentration of Zotepine can be increased when it is combined with Peginterferon alfa-2b.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Zotepine.
Pentobarbital
The metabolism of Zotepine can be increased when combined with Pentobarbital.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Zotepine.
Perazine
The risk or severity of adverse effects can be increased when Zotepine is combined with Perazine.
Perphenazine
The risk or severity of adverse effects can be increased when Perphenazine is combined with Zotepine.
Phenelzine
The risk or severity of adverse effects can be increased when Phenelzine is combined with Zotepine.
Phenobarbital
The metabolism of Zotepine can be increased when combined with Phenobarbital.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Zotepine is combined with Phenoxyethanol.
Phentermine
Zotepine may decrease the stimulatory activities of Phentermine.
PHENTERMINE RESIN
Zotepine may decrease the stimulatory activities of Phentermine.
Phenytoin
The metabolism of Zotepine can be increased when combined with Phenytoin.
Pimozide
The risk or severity of adverse effects can be increased when Pimozide is combined with Zotepine.
Pipamperone
The risk or severity of adverse effects can be increased when Zotepine is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Pipotiazine is combined with Zotepine.
Piribedil
The therapeutic efficacy of Piribedil can be decreased when used in combination with Zotepine.
Pirinitramide
The risk or severity of adverse effects can be increased when Zotepine is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Pizotifen is combined with Zotepine.
Pomalidomide
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Zotepine.
Posaconazole
The metabolism of Zotepine can be decreased when combined with Posaconazole.
Pramipexole
Zotepine may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Zotepine is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Prazepam is combined with Zotepine.
Pregabalin
The therapeutic efficacy of Zotepine can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Prilocaine is combined with Zotepine.
Primidone
The metabolism of Zotepine can be increased when combined with Primidone.
Procaine
The risk or severity of adverse effects can be increased when Procaine is combined with Zotepine.
Procarbazine
The risk or severity of adverse effects can be increased when Procarbazine is combined with Zotepine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Zotepine.
Promazine
The risk or severity of adverse effects can be increased when Promazine is combined with Zotepine.
Promethazine
The risk or severity of adverse effects can be increased when Promethazine is combined with Zotepine.
Proparacaine
The risk or severity of adverse effects can be increased when Proparacaine is combined with Zotepine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Zotepine.
Propoxyphene
The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Zotepine.
Protriptyline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Zotepine.
Pseudoephedrine
Zotepine may decrease the stimulatory activities of Pseudoephedrine.
Quazepam
The risk or severity of adverse effects can be increased when Quazepam is combined with Zotepine.
Quetiapine
The risk or severity of adverse effects can be increased when Quetiapine is combined with Zotepine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Quetiapine is combined with Zotepine.
Quinagolide
The therapeutic efficacy of Quinagolide can be decreased when used in combination with Zotepine.
Ramelteon
The risk or severity of adverse effects can be increased when Ramelteon is combined with Zotepine.
Ranolazine
The metabolism of Zotepine can be decreased when combined with Ranolazine.
Rasagiline
The risk or severity of adverse effects can be increased when Rasagiline is combined with Zotepine.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Zotepine.
Remoxipride
The risk or severity of adverse effects can be increased when Remoxipride is combined with Zotepine.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Zotepine.
Rifabutin
The metabolism of Zotepine can be increased when combined with Rifabutin.
Rifampin
The metabolism of Zotepine can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Zotepine can be increased when combined with Rifapentine.
Risperidone
The risk or severity of adverse effects can be increased when Risperidone is combined with Zotepine.
Rizatriptan
The risk or severity of adverse effects can be increased when Rizatriptan is combined with Zotepine.
Ropinirole
Zotepine may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Ropivacaine is combined with Zotepine.
Rotigotine
Zotepine may increase the sedative activities of Rotigotine.
Rucaparib
The metabolism of Zotepine can be decreased when combined with Rucaparib.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Zotepine.
Saquinavir
The metabolism of Zotepine can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Zotepine can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Zotepine can be decreased when used in combination with Sarilumab.
Scopolamine
The risk or severity of adverse effects can be increased when Scopolamine is combined with Zotepine.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Scopolamine is combined with Zotepine.
Secobarbital
The risk or severity of adverse effects can be increased when Secobarbital is combined with Zotepine.
Selegiline
The risk or severity of adverse effects can be increased when Selegiline is combined with Zotepine.
Sertindole
The risk or severity of adverse effects can be increased when Sertindole is combined with Zotepine.
Sertraline
The risk or severity of adverse effects can be increased when Zotepine is combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Zotepine.
Sildenafil
The metabolism of Zotepine can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Zotepine can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Zotepine can be increased when it is combined with Simeprevir.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Zotepine.
ST. JOHN'S WORT EXTRACT
The serum concentration of Zotepine can be decreased when it is combined with St. John's Wort.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Zotepine.
Sulfisoxazole
The metabolism of Zotepine can be decreased when combined with Sulfisoxazole.
Sulpiride
Zotepine may increase the antipsychotic activities of Sulpiride.
Sumatriptan
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Zotepine.
Sumatriptan Succinate
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Zotepine.
Suvorexant
Zotepine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Zotepine.
Tasimelteon
The risk or severity of adverse effects can be increased when Tasimelteon is combined with Zotepine.
Tedizolid
The risk or severity of adverse effects can be increased when Tedizolid Phosphate is combined with Zotepine.
Tedizolid Phosphate
The risk or severity of adverse effects can be increased when Tedizolid Phosphate is combined with Zotepine.
Telaprevir
The metabolism of Zotepine can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Zotepine can be decreased when combined with Telithromycin.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Zotepine.
Tenofovir Disoproxil
The metabolism of Zotepine can be decreased when combined with Tenofovir disoproxil.
Teriflunomide
The serum concentration of Zotepine can be decreased when it is combined with Teriflunomide.
Tetrabenazine
The risk or severity of adverse effects can be increased when Tetrabenazine is combined with Zotepine.
Tetracaine
The risk or severity of adverse effects can be increased when Tetracaine is combined with Zotepine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Tetracaine is combined with Zotepine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Zotepine.
Thalidomide
Zotepine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Theophylline
The metabolism of Zotepine can be decreased when combined with Theophylline.
Theophylline anhydrous
The metabolism of Zotepine can be decreased when combined with Theophylline.
Thiamylal
The risk or severity of adverse effects can be increased when Thiamylal is combined with Zotepine.
Thiopental
The risk or severity of adverse effects can be increased when Thiopental is combined with Zotepine.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Thiopental is combined with Zotepine.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Zotepine.
Thiothixene
The risk or severity of adverse effects can be increased when Thiothixene is combined with Zotepine.
Tiagabine
The risk or severity of adverse effects can be increased when Tiagabine is combined with Zotepine.
Tiapride
The risk or severity of adverse effects can be increased when Zotepine is combined with Tiapride.
Ticlopidine
The metabolism of Zotepine can be decreased when combined with Ticlopidine.
Tizanidine
The risk or severity of adverse effects can be increased when Tizanidine is combined with Zotepine.
Tocilizumab
The serum concentration of Zotepine can be decreased when it is combined with Tocilizumab.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Zotepine.
Topiramate
The risk or severity of adverse effects can be increased when Topiramate is combined with Zotepine.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Zotepine.
Tranylcypromine
The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Zotepine.
Trazodone
The risk or severity of adverse effects can be increased when Trazodone is combined with Zotepine.
Triazolam
The risk or severity of adverse effects can be increased when Triazolam is combined with Zotepine.
Triazulenone
The risk or severity of adverse effects can be increased when Zotepine is combined with Loprazolam.
Trifluoperazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Zotepine.
Triflupromazine
The risk or severity of adverse effects can be increased when Triflupromazine is combined with Zotepine.
Trimipramine
The risk or severity of adverse effects can be increased when Trimipramine is combined with Zotepine.
Triprolidine
The risk or severity of adverse effects can be increased when Triprolidine is combined with Zotepine.
Urethane
The risk or severity of adverse effects can be increased when Ethyl carbamate is combined with Zotepine.
Valproate
The risk or severity of adverse effects can be increased when Valproic Acid is combined with Zotepine.
Valproic Acid
The risk or severity of adverse effects can be increased when Valproic Acid is combined with Zotepine.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Zotepine.
Venlafaxine
The risk or severity of adverse effects can be increased when Zotepine is combined with Venlafaxine.
Verapamil
The metabolism of Zotepine can be decreased when combined with Verapamil.
Vigabatrin
The risk or severity of adverse effects can be increased when Vigabatrin is combined with Zotepine.
Vilazodone
The risk or severity of adverse effects can be increased when Vilazodone is combined with Zotepine.
Voriconazole
The metabolism of Zotepine can be decreased when combined with Voriconazole.
Vortioxetine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Zotepine.
Xylazine
The risk or severity of adverse effects can be increased when Zotepine is combined with Xylazine.
Zaleplon
The risk or severity of adverse effects can be increased when Zaleplon is combined with Zotepine.
Ziconotide
The risk or severity of adverse effects can be increased when Ziconotide is combined with Zotepine.
Ziprasidone
The risk or severity of adverse effects can be increased when Ziprasidone is combined with Zotepine.
Zolmitriptan
The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Zotepine.
Zolpidem
Zotepine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Zonisamide is combined with Zotepine.
Zopiclone
The risk or severity of adverse effects can be increased when Zopiclone is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Zotepine.
